Reverse or inverted dipping (ie, the phenomenon characterized by higher nighttime compared with daytime blood pressure values) is an alteration of circadian blood pressure rhythm frequently documented in hypertension, type 2 diabetes mellitus, chronic kidney disease, and sleep apnea syndrome, and generally regarded as a harmful condition. Available literature on the clinical and prognostic implications of reverse dipping is scanty. The present article will review a number of relevant issues concerning reverse dipping, in particular: (1) its possible mechanisms; (2) prevalence and clinical correlates, (3) concomitant cardiac and extracardiac subclinical organ damage; (4) association with acute and chronic cardiovascular diseases; (5) prognostic value in predicting cardiovascular events and mortality; and (6) therapeutic interventions aimed at reverting this abnormal circadian blood pressure rhythm.
| INTRODUCTION
During the past 4 decades, combined office and out-of-office blood pressure (BP) measurements (self-measured home BP or 24-hour ambulatory BP monitoring) have been recognized to provide a more accurate assessment of BP status and are increasingly applied in clinical and research settings. Overall, combined office and home or 24-hour ambulatory BP measurements define four different BP phenotypes: (1) sustained normotension (ie, normal office and out-of-office BP); (2) sustained hypertension (elevated in-office and out-of-office BP); (3) white-coat hypertension, alternatively termed isolated clinic hypertension (elevated office and normal out-of-office BP); and (4) masked hypertension (normal office and elevated out-of-office BP). These BP patterns have been reported to substantially differ in terms of prevalence, demographic and clinical characteristics, and burden of subclinical organ damage as well as risk of cardiovascular morbidity and mortality.
2-4
Furthermore, by providing a much larger number of BP readings during 24 hours compared with office and home BP measurements, ambulatory BP monitoring offers the opportunity to evaluate day-night BP variability. A circadian rhythm of BP has been documented in the majority of normotensive and hypertensive individuals, with nighttime BP values being 10% to 20% lower than daytime values due to the reduction in sympathetic tone and the parallel increase in vagal activity during the sleep period. Historically, a nocturnal BP drop lower than 10% has been largely accepted to define patients with abnormal circadian rhythm (nondippers). 5, 6 A growing amount of evidence indicates that nondippers have more marked cardiac and extracardiac organ damage compared with patients with preserved nocturnal BP fall and, more importantly, an increased likelihood of cardiovascular events. [7] [8] [9] [10] Reverse or inverted dipping (ie, the condition characterized by unchanged or even increased nighttime BP compared with daytime values) represents an extreme, not rare, alteration in circadian BP rhythm, usually regarded as a particularly harmful BP phenotype. Unfortunately, available literature on clinical and prognostic implications of reverse dipping (RD) is limited and a comprehensive report of key features of this BP pattern is lacking. Thus, the present article will review a number of issues concerning the paradoxical increase in nighttime BP with particular attention to: (1) possible mechanisms of altered circadian BP rhythm; (2) prevalence and clinical correlates; (3) the association with subclinical organ damage; (4) the association with overt cardiovascular disease; (5) prognostic significance; and (6) therapeutic interventions.
| SEARCH METHOD
A systematic computerized literature search was performed using PubMed, Ovid, Embase, and Cochrane Library databases from January 1, 1978, to January 31, 2017. Studies were identified by crossing the following search terms: "ambulatory blood pressure," "nocturnal blood pressure," "reverse dipping," "inverted dipping," "riser pattern,"
"altered circadian BP rhythm," "hypertension," "target organ damage,"
"cardiac disease," "cerebrovascular disease," and "mortality." Checks of the reference lists of selected papers and pertinent reviews complemented the electronic search. Data were extracted by two independent investigators (CC and CS).
| Pathogenetic mechanisms
A blunted or absent BP reduction during the nighttime period is a multifactorial condition that is more frequently documented in patients with secondary hypertension, severe or refractory essential hypertension, preeclampsia, chronic renal disease, type 1 and 2 diabetes mellitus, sleep-apnea syndrome, and autonomic dysfunction. General agreement exists on the direct relationship between the magnitude of nocturnal BP fall and the decrease in sympathetic activity, driving a reduction in cardiac output, peripheral resistance, and heart rate.
Clinical studies have documented diurnal variations of circulating levels of norepinephrine and epinephrine that reaches a nadir during nighttime sleep.
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Our group investigated the association between nocturnal BP patterns and sympathetic drive, as assessed by direct microneurographic measurement of sympathetic activity at the peroneal muscle in patients with essential hypertension. A stepwise increase in muscle sympathetic nerve traffic occurred from normotensive controls to extreme dipper, dipper, nondipper, and RD hypertensives. Notably, day-night BP difference in the whole study population was inversely related to sympathetic nerve traffic (r=−.76, P<.0001), suggesting that sympathetic activation in human hypertension may potently affect circadian BP variations. 12 Also, in patients with obstructive sleep apnea, a condition frequently associated with nocturnal hypertension, increased sympathetic tone responsible for BP elevations during apneic episodes has been documented in microneurographic studies.
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Impaired renal capacity to excrete sodium has been shown to be a factor leading to a blunted nocturnal BP fall. 14 This condition has been associated with reduced daytime sodium excretion, and the nocturnal BP increase via the pressure-natriuresis mechanism is a likely compensatory mechanism to increase sodium excretion and preserve sodium balance. 15 The role of sodium in regulating circadian BP rhythm is also supported by intervention studies showing that a dipping pattern is restored after salt restriction or administration of diuretics. 16 Since preserved glomerular filtration function is a major determinant of sodium balance, deterioration in renal function is generally paralleled by a reduction of the physiologic fall in nighttime BP. Cystatin C is a more sensitive marker of glomerular filtration rate than serum creatinine, as its circulating levels are less affected by confounders such as age, sex, and muscle mass. Among patients with essential hypertension, this compound has been found to be significantly higher in patients with RD than in patients with dipping pattern. The Chronic Kidney Disease Japan Cohort (CKDJC), an observational study aimed at investigating clinical correlates of ambulatory BP monitoring among patients with CKD showed that 167 (15.5%) of 1075 patients had a nocturnal BP rise. 23 The prevalence of risers was higher among patients with CKD stage 4 and 5 compared with those with stage 3, among diabetic than nondiabetic patients, and among patients with nocturia. The association between day-night BP behavior and white matter changes and its interaction with obstructive sleep apnea among 703 normotensive adults (mean age 59 years) has been investigated by Lee and coworkers. 24 In this relatively older population, 13% were reverse dippers and exhibited a greater prevalence of moderate to severe obstructive sleep apnea than other groups (13.5% vs 9.0% in nondippers and 7.5% in dippers). ) participants.
| Association with subclinical organ damage
In contrast to the above-mentioned echocardiographic studies, the AASK investigators were able to find only marginal differences in LVH prevalence among various ambulatory day/night BP phenotypes
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( Table 1 ).
In the Coronary Artery Risk Development in Young Adults (CARDIA) study, young adults with less pronounced or absent nocturnal BP fall at the initial evaluation had the greatest risk of developing coronary calcification at 10 to 15 years of follow-up. In the AASK trial, nondippers and participants with RD exhibited a higher prevalence of proteinuria (35% and 30%, respectively) compared with dippers (20% 
| Association with cardiovascular disease
A further line of research has investigated the link between RD and overt cardiovascular disease in a variety of clinical settings such as cognitive impairment/vascular dementia, stroke, coronary heart disease, and heart failure. In a study designed to delineate the relation- 
| Prognostic significance
The value of RD pattern in predicting cardiovascular events and allcause mortality has been addressed in population-based samples and in patients with hypertension, type 2 diabetes mellitus, CKD, stroke, and heart failure ( Table 2 ). The first report in this research area was published by Ohkubo and colleagues 10 20 years ago and examined 1542 residents in the Ohasama district, Japan. The relationship between the decline in nocturnal BP and mortality was investigated by taking into account several potential confounders such as age, sex, smoking status, history of cardiovascular disease, 24-hour systolic BP, and use of antihypertensive medication. The risk of total mortality in patients with RD was approximately two-fold higher than in dippers (P=.02). Of note, the increased mortality risk documented in patients with RD was mainly attributable to cardiovascular causes. In a survey performed in a Belgium primary care practice including 374 elderly patients without major cardiovascular events or other comorbidities at baseline, RD had a prognostic significance in univariable analyses but lost its predictive value after adjustment for confounders, including 24-hour BP. 44 A pilot study involving 97 hypertensive diabetic patients at high risk of cardiovascular events revealed that RD status was independently related to higher rates of composite outcome (encompassing myocardial infarction, stroke, or cardiovascular death), compared with other patients with dipping or nondipping profile during a follow-up period of 2.6 years. 45 In the setting of CKD, two studies consisting of 1024 individuals evaluated the risk of end-stage renal disease and nonfatal/fatal cardiovascular events associated with RD.
Both reports consistently documented that patients with RD had an increased risk of renal death and cardiovascular events compared with patients with preserved circadian BP rhythm, independently of 24-hour systolic BP levels.
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T A B L E 2 Summary of studies reporting data on prognostic significance of reverse dipping pattern 48 in 516 hospitalized patients with heart failure and preserved ejection fraction. The RD subgroup had a significantly higher incidence of the composite outcome (all-cause mortality and cardiovascular events) than the other subgroups.
In a prospective study performed in 426 patients with cerebral infarction followed-up for an average period of 7.6 years to detect recurrent cerebral events or all-cause mortality, RD pattern diagnosed within 2 weeks after hospitalization was associated with an increased rate of mortality. were included in the reports (sample size range, 401-3468 participants). A total of 890 cardiovascular events (12.9%) were recorded among follow-up periods ranging from 41 to 120 months. Figure 2 shows event rates recorded in dipper, nondipper, and reverse dipper hypertensive patients in the five studies.
A progressive increase in cardiovascular events occurred from dipper (10.2%) to nondipper (12.7%) and reverse dipper participants (24.1%). The incidence of cardiovascular events in extreme dippers (15.6%) was provided in only three of five studies.
In the pooled population, the risk of nonfatal and fatal cardiovascular events in patients with RD was 2.5-fold greater than in dippers (95% CI, 2.11-2.96, P<.01; Figure 3 ) and persisted to be 2.1-fold higher compared with nondippers (95% CI, 1.77-2.45, P<.001; Figure 4 ).
The risk associated with RD pattern remained significantly increased when compared with extreme dippers (data not shown).
Finally, a funnel plot excluded the presence of publication bias, and sensitivity analysis showed that the final result was not substantially affected by a single study effect.
| Therapeutic interventions
Although reversal of altered circadian BP profiles is considered a therapeutic target for improving cardiovascular prognosis in hypertensive 56 BP reductions induced by cilnidipine were more pronounced at nighttime than daytime in patients with RD, similar at nighttime as daytime in nondippers, and more pronounced at daytime than nighttime in dippers. In a retrospective analysis including 1279 patients, telmisartan (a long-acting angiotensin II receptor antagonist with a high smoothness index) normalized circadian BP pattern to a dipper profile in a larger proportion of patients compared with ramipril and reduced early-morning systolic BP surge. 57 The benefit of ameliorating nighttime BP control has recently been investigated by the MAPEC study. 58 The investigators evaluated whether bedtime therapy with one or more hypertensive drugs was able to control BP and reduce cardiovascular risk more effectively than F I G U R E 3 Relative risk of cardiovascular (CV) events, 95% confidence intervals (CIs), and relative weight in reverse dippers (n=696) vs dippers (n=2900) F I G U R E 4 Relative risk of cardiovascular (CV) events, 95% confidence intervals (CIs) and relative weight, in reverse dippers (n=696) vs nondippers (n=2712) conventional therapy administration (ie, all antihypertensive drugs taken in the morning hours). After a follow-up of 5.6 years, participants taking one or more BP-lowering medications at bedtime had a lower nighttime BP as well as a reduced prevalence of nondipping/ RD status than patients taking all drugs upon awakening. Importantly, the tighter control in nocturnal BP was associated with a substantial decrease (−60%) in relative risk of cardiovascular events.
It should be noted, however, that information on treatments aimed at restoring an abnormal circadian BP pattern remains scanty and has been provided by only a few research groups.
| CONCLUSIONS
A paradoxical BP increase during sleep has been documented during 24-hour BP monitoring. This impaired circadian BP rhythm, although of marginal prevalence in general population samples (<5%), has been reported to be up to 10 times more prevalent in patients with hypertension, type 2 diabetes mellitus, CKD, and sleep apnea syndrome.
Studies targeting the association of this condition with subclinical organ damage at the cardiac and extracardiac levels failed to provide univocal findings, although they support the view that RD is a risk factor for LVH, carotid abnormalities, proteinuria, and microalbuminuria.
A stronger body of evidence on the adverse clinical significance of RD pattern comes from studies addressing its relationship with incident cardiovascular events, where RD turned out to be a powerful marker of adverse cardiovascular prognosis, after adjusting for traditional risk factors.
Because of the high cardiovascular risk associated with RD, an appropriate antihypertensive chronotherapeutic approach to this condition should be performed to improve cardiovascular prevention.
Further studies to assess the beneficial effects on cardiovascular prognosis of therapeutic interventions aimed to normalize circadian BP pattern are needed.
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